Clinical trial reportNeuro-oncologyPublished
Phase I/II and window-of-opportunity study of pamiparib and metronomic temozolomide for recurrent isocitrate dehydrogenase mutant gliomas
Regional connection
Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source
- Institutions
- Perelman School of Medicine, University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Neuro-oncology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Glioma; Brain Neoplasms; Neoplasm Recurrence, Local; Isocitrate Dehydrogenase; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Prognosis; Survival Rate; Follow-Up Studies; Maximum Tolerated Dose; Mutation
- PubMed ID
- 41099363
- PubMed Central ID
- PMC12979031
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked